Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

891 ARTÍCULOS , VIENDO DEL 61 AL 75

An insight into the mechanism of DNA damage response in plants- role of SUPPRESSOR OF GAMMA RESPONSE 1: An overview

Mahapatra K, Roy S.

Mutat Res. 2020 Jan-Apr;819-820:111689. doi: 10.1016/j.mrfmmm.2020.111689. Epub 2020 Jan 23.

The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich's Ataxia

La Rosa P, Bertini ES, Piemonte F.

Int J Mol Sci. 2020 Jan 30;21(3):916. doi: 10.3390/ijms21030916.

An Oculopharyngeal Subtype of Guillain-Barré Syndrome Sparing the Trochlear and Abducens Nerves

Arakawa M, Yamazaki M, Toda Y, Ozawa A, Kimura K.

Intern Med. 2020 May 1;59(9):1215-1217. doi: 10.2169/internalmedicine.3395-19. Epub 2020 Feb 5.

Evaluation of neurobehavioral abnormalities and immunotoxicity in response to oral imidacloprid exposure in domestic chickens (Gallus gallus domesticus)

Franzen-Klein D, Jankowski M, Roy CL, Nguyen-Phuc H, Chen D, Neuman-Lee L, Redig P, Ponder J.

J Toxicol Environ Health A. 2020 Jan 17;83(2):45-65. doi: 10.1080/15287394.2020.1723154. Epub 2020 Feb 5.

Construct Validity of the Observable Movement Quality Scale in Pediatrics: Hypothesis Testing of a Formative Measurement Model

Dekkers LMA, Janssen AJWM, Donders ART, Nijhuis-van der Sanden MWG, de Swart BJM.

Phys Ther. 2020 Feb 7;100(2):346-358. doi: 10.1093/ptj/pzz166.

Genetics of syndromic ocular coloboma: CHARGE and COACH syndromes

George A, Cogliati T, Brooks BP.

Exp Eye Res. 2020 Apr;193:107940. doi: 10.1016/j.exer.2020.107940. Epub 2020 Feb 4.

Neuroimaging Biomarkers in SCA2 Gene Carriers

Mascalchi M, Vella A.

Int J Mol Sci. 2020 Feb 4;21(3):1020. doi: 10.3390/ijms21031020.

Teaching NeuroImages: The dentate sign in subacute cerebellar ataxia: Metronidazole neurotoxicity

Jiménez MT, Gándara PS, Espay AJ.

Neurology. 2020 Feb 25;94(8):e878-e879. doi: 10.1212/WNL.0000000000009006. Epub 2020 Feb 7.

Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study

Bonnard C, Wirth T, Gebus O, Fahrer P, Montaut S, Robelin L, Tuzin N, Tranchant C, Anheim M.

J Neurol. 2020 Mar;267(3):855-859. doi: 10.1007/s00415-020-09737-z. Epub 2020 Feb 7.

Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease

Angelopoulou E, Paudel YN, Piperi C.

J Mol Med (Berl). 2020 Mar;98(3):325-334. doi: 10.1007/s00109-020-01885-z. Epub 2020 Feb 8.

Phase I randomized single-blinded controlled study investigating the potential benefit of aerobic exercise in degenerative cerebellar disease

Barbuto S, Martelli D, Omofuma IB, Lee N, Kuo SH, Agrawal S, Lee S, O'Dell M, Stein J.

Clin Rehabil. 2020 May;34(5):584-594. doi: 10.1177/0269215520905073. Epub 2020 Feb 10.

Posterior column ataxia with retinitis pigmentosa (PCARP) in an Iranian patient associated with the FLVCR1 gene

Beigi F, Del Pozo-Valero M, Martin-Merida I, Vahidi Mehrjardi MY, Manaviat MR, Sherafat A, Ayuso C, Ghasemi N.

Ophthalmic Genet. 2020 Feb;41(1):90-92. doi: 10.1080/13816810.2020.1720743. Epub 2020 Feb 10.

Role of Risk Factors in Developing Osmotic Demyelination Syndrome During Correction of Hyponatremia: A Case Study

Reijnders TDY, Janssen WMT, Niamut SML, Kramer AB.

Cureus. 2020 Jan 2;12(1):e6547. doi: 10.7759/cureus.6547.

CRL4(Cdt2): Coupling Genome Stability to Ubiquitination

Panagopoulos A, Taraviras S, Nishitani H, Lygerou Z.

Trends Cell Biol. 2020 Apr;30(4):290-302. doi: 10.1016/j.tcb.2020.01.005. Epub 2020 Feb 7.

Ayurvedic approach for management of Wilson's disease: A case report

Kumar T, Thakar A.

J Ayurveda Integr Med. 2020 Apr-Jun;11(2):177-180. doi: 10.1016/j.jaim.2019.09.004. Epub 2020 Feb 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias